$TRXA
T-REX Acquisition Corp.

2022 Q2 Form 10-Q Financial Statement

#000147793222003847 Filed on May 23, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $35.60K $26.31K $0.00
YoY Change
Cost Of Revenue $2.300K $39.65K $0.00
YoY Change
Gross Profit $33.30K -$13.35K $0.00
YoY Change
Gross Profit Margin 93.54% -50.75%
Selling, General & Admin $1.073M $79.96K $840.8K
YoY Change 2231.94% 82.14% 1927.03%
% of Gross Profit 3223.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $23.87K
YoY Change
% of Gross Profit 71.68%
Operating Expenses $302.5K $79.96K $840.8K
YoY Change 557.27% 82.14% 1927.06%
Operating Profit -$269.2K -$93.31K -$840.8K
YoY Change 112.55% 1927.06%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$287.0K -$93.31K -$840.8K
YoY Change 523.55% 112.55% 1927.06%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$287.0K -$93.31K -$840.8K
YoY Change 523.63% 112.55% 1927.06%
Net Earnings / Revenue -806.24% -354.73%
Basic Earnings Per Share
Diluted Earnings Per Share -$16.35K -$5.771K -$52.00K
COMMON SHARES
Basic Shares Outstanding 16.17M shares 16.17M shares 16.17M shares
Diluted Shares Outstanding 16.17M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.320K $46.33K $1.360K
YoY Change
Cash & Equivalents $104.00 $20.03K $1.360K
Short-Term Investments $9.210K $26.31K
Other Short-Term Assets $47.83K
YoY Change
Inventory
Prepaid Expenses $47.83K
Receivables
Other Receivables
Total Short-Term Assets $57.15K $46.33K $1.360K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $421.6K $437.5K $356.4K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.57K $10.57K
YoY Change
Other Assets $408.8K
YoY Change
Total Long-Term Assets $841.0K $448.1K $356.4K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $57.15K $46.33K $1.360K
Total Long-Term Assets $841.0K $448.1K $356.4K
Total Assets $898.2K $494.4K $357.8K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.95K $22.97K $22.97K
YoY Change 22870.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $139.0K $52.97K $22.97K
YoY Change 201.26% 52871.0% 2046.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $139.0K $52.97K $22.97K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $139.0K $52.97K $22.97K
YoY Change 201.26% 52871.0% 2046.82%
SHAREHOLDERS EQUITY
Retained Earnings -$4.161M -$3.874M -$3.780M
YoY Change 45.15%
Common Stock $19.57K $16.17K $16.17K
YoY Change 33.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $759.2K $441.5K $334.8K
YoY Change
Total Liabilities & Shareholders Equity $898.2K $494.4K $357.8K
YoY Change

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$287.0K -$93.31K -$840.8K
YoY Change 523.63% 112.55% 1927.06%
Depreciation, Depletion And Amortization $23.87K
YoY Change
Cash From Operating Activities -$130.0K -$100.2K -$3.120K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$7.960K -$81.14K -$356.4K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$7.960K -$81.14K -$356.4K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 118.0K 200.0K 360.9K
YoY Change
NET CHANGE
Cash From Operating Activities -130.0K -100.2K -3.120K
Cash From Investing Activities -7.960K -81.14K -356.4K
Cash From Financing Activities 118.0K 200.0K 360.9K
Net Change In Cash -19.93K 18.68K 1.360K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$130.0K -$100.2K -$3.120K
Capital Expenditures -$7.960K -$81.14K -$356.4K
Free Cash Flow -$122.1K -$19.04K $353.3K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1124 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
30000 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
45000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
52971 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
46124 USD
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16169106 shares
CY2022Q1 us-gaap Cash
Cash
20029 USD
CY2021Q2 us-gaap Cash
Cash
0 USD
CY2022Q1 trxa Crypto Currency Held Current
CryptoCurrencyHeldCurrent
26305 USD
CY2021Q2 trxa Crypto Currency Held Current
CryptoCurrencyHeldCurrent
0 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
46334 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
0 USD
CY2022Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
437544 USD
CY2021Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
0 USD
CY2022Q1 trxa Facility Deposit
FacilityDeposit
10570 USD
CY2021Q2 trxa Facility Deposit
FacilityDeposit
0 USD
CY2022Q1 us-gaap Assets
Assets
494448 USD
CY2021Q2 us-gaap Assets
Assets
0 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
22971 USD
CY2022Q1 us-gaap Liabilities
Liabilities
52971 USD
CY2021Q2 us-gaap Liabilities
Liabilities
46124 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16169106 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14669106 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
16169 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
14669 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3620116 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2805766 USD
CY2022Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
678925 USD
CY2021Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
0 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3873733 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2866559 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
441477 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-46124 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
494448 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2022Q1 us-gaap Revenues
Revenues
26305 USD
CY2021Q1 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
26305 USD
us-gaap Revenues
Revenues
0 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39654 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39654 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
-13349 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Gross Profit
GrossProfit
-13349 USD
us-gaap Gross Profit
GrossProfit
0 USD
CY2022Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
637 USD
CY2021Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
2150 USD
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
4433 USD
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
8167 USD
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
41000 USD
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
24000 USD
us-gaap Professional Fees
ProfessionalFees
113330 USD
us-gaap Professional Fees
ProfessionalFees
66000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
770850 USD
us-gaap Share Based Compensation
ShareBasedCompensation
300000 USD
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
30000 USD
CY2021Q1 us-gaap Management Fee Expense
ManagementFeeExpense
15000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
90000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
45000 USD
CY2022Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
8326 USD
CY2021Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
2751 USD
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
15212 USD
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
2750 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
79963 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
43901 USD
us-gaap Operating Expenses
OperatingExpenses
993825 USD
us-gaap Operating Expenses
OperatingExpenses
421917 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-93312 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-43901 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1007174 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-421917 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
0 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-93312 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-43901 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1007174 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-421917 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-93312 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-43901 USD
us-gaap Net Income Loss
NetIncomeLoss
-1007174 USD
us-gaap Net Income Loss
NetIncomeLoss
-421917 USD
CY2022Q1 trxa Net Loss Per Common Share Basic Diluted
NetLossPerCommonShareBasicDiluted
-0.01
CY2021Q1 trxa Net Loss Per Common Share Basic Diluted
NetLossPerCommonShareBasicDiluted
-0.00
trxa Net Loss Per Common Share Basic Diluted
NetLossPerCommonShareBasicDiluted
-0.06
trxa Net Loss Per Common Share Basic Diluted
NetLossPerCommonShareBasicDiluted
-0.04
CY2022Q1 trxa Weighted Average Number Of Common Shares Outstanding Basic Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicDiluted
16169106 shares
CY2021Q1 trxa Weighted Average Number Of Common Shares Outstanding Basic Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicDiluted
13776217 shares
trxa Weighted Average Number Of Common Shares Outstanding Basic Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicDiluted
15851171 shares
trxa Weighted Average Number Of Common Shares Outstanding Basic Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicDiluted
9752330 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-476843 USD
CY2020Q3 trxa Shares Issued From To Be Issued Amount
SharesIssuedFromToBeIssuedAmount
0 USD
CY2020Q3 trxa Shares Issued From Private Sale Amount
SharesIssuedFromPrivateSaleAmount
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
300000 USD
CY2020Q3 trxa Shares Issued For Related Party Debt Conversion Amount
SharesIssuedForRelatedPartyDebtConversionAmount
473616 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-336539 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-39766 USD
CY2020Q4 trxa Shares Issued For Related Party Debt Conversion Amount
SharesIssuedForRelatedPartyDebtConversionAmount
80173 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-41479 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1072 USD
CY2021Q1 trxa Shares Issued For Related Party Debt Conversion Amount
SharesIssuedForRelatedPartyDebtConversionAmount
44873 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-100 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-46024 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-46124 USD
CY2021Q3 trxa Shares Issued For Related Party Debt Conversion Amount
SharesIssuedForRelatedPartyDebtConversionAmount
45000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-74181 USD
CY2021Q4 trxa Shares To Be Issued For Subscriptions Received
SharesToBeIssuedForSubscriptionsReceived
360875 USD
CY2021Q4 trxa Share Based Expense For Warrants Issued
ShareBasedExpenseForWarrantsIssued
770850 USD
CY2021Q4 us-gaap Stock Issued1
StockIssued1
118050 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-840805 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
334789 USD
CY2022Q1 trxa Shares To Be Issued For Subscriptions Received
SharesToBeIssuedForSubscriptionsReceived
200000 USD
CY2022Q1 trxa Share Based Expense For Warrants Issued
ShareBasedExpenseForWarrantsIssued
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-93312 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
441477 USD
us-gaap Net Income Loss
NetIncomeLoss
-1007174 USD
us-gaap Net Income Loss
NetIncomeLoss
-421917 USD
us-gaap Share Based Compensation
ShareBasedCompensation
770850 USD
us-gaap Share Based Compensation
ShareBasedCompensation
300000 USD
trxa Change In Crypto Currency Held
ChangeInCryptoCurrencyHeld
26305 USD
trxa Change In Deposits
ChangeInDeposits
10570 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
148049 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
125043 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21848 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20029 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3126 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103302 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
437544 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-437544 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Proceeds From Loans
ProceedsFromLoans
560875 USD
us-gaap Proceeds From Loans
ProceedsFromLoans
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
560875 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20029 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
598662 USD
us-gaap Stock Issued1
StockIssued1
163050 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
1 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</p>
trxa Crypto Currency Held
CryptoCurrencyHeld
<p style="font-size:10pt;font-family:times new roman;margin:0px">The Company considers its Crypto currency held to be highly liquid investments with a maturity of three months or less when mined to be cash equivalents. In order to value the Bitcoin that we mined and maintain in our slush pool wallet, we mark to market using the last quote at 11:59 on the last day of the period. We then multiply the quote against the (in this case fractional) number of bitcoin we own. That gives the dollar value of our position.</p>
us-gaap Revenues
Revenues
26305 USD
CY2022Q1 trxa Operating Loss Carryforward
OperatingLossCarryforward
-3873733 USD
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
813484 USD
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21 pure
trxa Deferred Tax Asset For Future Periods
DeferredTaxAssetForFuturePeriods
P20Y
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
813484 USD
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
813484 USD
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
503709 USD
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
813484 USD
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
503709 USD
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1435333 shares
CY2021 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
598662 USD
CY2021Q2 trxa Conversion Of Stock Shares
ConversionOfStockShares
11380198 shares
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3873733 USD
CY2022Q1 trxa Working Capital Deficit
WorkingCapitalDeficit
-6637 USD
trxa Management Fees
ManagementFees
30000 USD
trxa Management Fees
ManagementFees
60000 USD
CY2022Q1 us-gaap Due To Officers Or Stockholders Current And Noncurrent
DueToOfficersOrStockholdersCurrentAndNoncurrent
43050 USD
CY2022Q1 trxa Due To Related Parties
DueToRelatedParties
118050 USD
CY2022Q1 trxa Management Fees
ManagementFees
30000 USD
CY2020Q1 trxa Shares Issued For Serivces Rendered Shares
SharesIssuedForSerivcesRenderedShares
300000 shares
CY2020Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
8900000 shares
CY2020Q2 trxa Common Stock Shares Issued Upon Debt Conversion Amount
CommonStockSharesIssuedUponDebtConversionAmount
473616 USD
CY2020Q3 trxa Prepayment For Future Expense
PrepaymentForFutureExpense
200198 USD
CY2021Q1 trxa Shares Issued For Serivces Rendered Shares
SharesIssuedForSerivcesRenderedShares
980000 shares
CY2021Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
450000 shares
CY2021Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
45000 USD
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1050000 shares
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
80000 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
250000 shares
CY2014Q2 trxa Description Of Warrants Exercise
DescriptionOfWarrantsExercise
Each Unit shall consist of (a) one (1) share of common stock and (b) a combination of series A warrants (which may be exercised within three (3) years) and series B warrants exercised within five (5) years of the consummation of a merger

Files In Submission

Name View Source Status
0001477932-22-003847-index-headers.html Edgar Link pending
0001477932-22-003847-index.html Edgar Link pending
0001477932-22-003847.txt Edgar Link pending
0001477932-22-003847-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trxa-20220331.xsd Edgar Link pending
trxa-20220331_cal.xml Edgar Link unprocessable
trxa-20220331_def.xml Edgar Link unprocessable
trxa-20220331_lab.xml Edgar Link unprocessable
trxa-20220331_pre.xml Edgar Link unprocessable
trxa_10q.htm Edgar Link pending
trxa_10q_htm.xml Edgar Link completed
trxa_ex311.htm Edgar Link pending
trxa_ex321.htm Edgar Link pending